[PLX] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
12-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- -5.73%
YoY- 22.20%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 2,469 2,081 -11,195 1,384 1,122 48 2,362 0.74%
PBT -15,141 -2,624 -12,419 -8,469 -10,885 968 968 -
Tax 916 -189 -85,260 57 0 -1,741 -27,616 -
NP -15,141 -2,624 72,900 -8,469 -10,885 -9,877 -8,913 9.22%
Tax Rate - - - - - 179.86% 2,852.89% -
Total Cost 17,610 4,705 -84,095 9,853 12,007 9,925 11,275 7.70%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -613.24 -126.09 -651.18 -611.92 -970.14 -20,577.08 -377.35 8.42%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -1.08 -0.21 7.31 -0.91 -1.18 -1.07 -1.01 1.12%
EPS Diluted -1.04 -0.21 7.31 -0.91 -1.17 -1.07 -1.01 0.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.